| Product NDC: | 0548-9090 |
| Proprietary Name: | AMPHADASE |
| Non Proprietary Name: | hyaluronidase |
| Active Ingredient(s): | 150 [USP'U]/mL & nbsp; hyaluronidase |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0548-9090 |
| Labeler Name: | Amphastar Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021665 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20041026 |
| Package NDC: | 0548-9090-10 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0548-9090-10) > 1 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 0548-9090-10 |
| Proprietary Name | AMPHADASE |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0548-9090-10) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0548-9090 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | hyaluronidase |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20041026 |
| Marketing Category Name | NDA |
| Labeler Name | Amphastar Pharmaceuticals, Inc. |
| Substance Name | HYALURONIDASE |
| Strength Number | 150 |
| Strength Unit | [USP'U]/mL |
| Pharmaceutical Classes | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |